Jeff Van Baal

716 total citations
8 papers, 506 citations indexed

About

Jeff Van Baal is a scholar working on Endocrinology, Diabetes and Metabolism, Occupational Therapy and Rehabilitation. According to data from OpenAlex, Jeff Van Baal has authored 8 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Occupational Therapy and 6 papers in Rehabilitation. Recurrent topics in Jeff Van Baal's work include Diabetic Foot Ulcer Assessment and Management (8 papers), Pressure Ulcer Prevention and Management (7 papers) and Wound Healing and Treatments (6 papers). Jeff Van Baal is often cited by papers focused on Diabetic Foot Ulcer Assessment and Management (8 papers), Pressure Ulcer Prevention and Management (7 papers) and Wound Healing and Treatments (6 papers). Jeff Van Baal collaborates with scholars based in Netherlands, United Kingdom and Denmark. Jeff Van Baal's co-authors include Frans Nollet, Sicco A. Bus, Tessa E. Busch‐Westbroek, Mark P. Arts, Mirjam de Haart, Roelof Waaijman, Michael Edmonds, Edward B. Jude, Alexandra Jirkovská and Maximilian Spraul and has published in prestigious journals such as Diabetes Care, Journal of Diabetes and its Complications and BMC Surgery.

In The Last Decade

Jeff Van Baal

8 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeff Van Baal Netherlands 6 460 339 277 92 44 8 506
Carlo Caravaggi Italy 7 500 1.1× 393 1.2× 340 1.2× 77 0.8× 42 1.0× 7 536
Ewan M Kinnear Australia 13 534 1.2× 388 1.1× 297 1.1× 123 1.3× 55 1.3× 23 655
Catherine Gooday United Kingdom 14 612 1.3× 400 1.2× 266 1.0× 136 1.5× 19 0.4× 41 694
Lorraine Loretz United States 7 414 0.9× 294 0.9× 173 0.6× 197 2.1× 33 0.8× 12 524
Elisabetta Iacopi Italy 13 336 0.7× 258 0.8× 168 0.6× 116 1.3× 18 0.4× 39 472
Atsuko Kitagawa Japan 12 209 0.5× 312 0.9× 398 1.4× 170 1.8× 19 0.4× 20 506
James W. Stavosky United States 7 421 0.9× 343 1.0× 214 0.8× 110 1.2× 14 0.3× 12 507
David G. Armstrong United States 5 459 1.0× 336 1.0× 206 0.7× 144 1.6× 30 0.7× 7 541
Douglas P. Murdoch United States 7 571 1.2× 441 1.3× 217 0.8× 136 1.5× 47 1.1× 9 671
Charles A. Patout United States 9 317 0.7× 203 0.6× 194 0.7× 73 0.8× 19 0.4× 13 355

Countries citing papers authored by Jeff Van Baal

Since Specialization
Citations

This map shows the geographic impact of Jeff Van Baal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Van Baal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Van Baal more than expected).

Fields of papers citing papers by Jeff Van Baal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Van Baal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Van Baal. The network helps show where Jeff Van Baal may publish in the future.

Co-authorship network of co-authors of Jeff Van Baal

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Van Baal. A scholar is included among the top collaborators of Jeff Van Baal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Van Baal. Jeff Van Baal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
3.
Horumpende, Pius, Stephen E. Mshana, Andrew Mganga, et al.. (2021). Antibiotic resistance in aerobic bacterial isolates from infected diabetic foot ulcers in North Eastern Tanzania: an urgent call to establish a hospital antimicrobial stewardship committee. International Journal of Basic & Clinical Pharmacology. 10(10). 1163–1163. 1 indexed citations
4.
Siersma, Volkert, Hanne Thorsen, P. Holstein, et al.. (2017). Diabetic complications do not hamper improvement of health-related quality of life over the course of treatment of diabetic foot ulcers – the Eurodiale study. Journal of Diabetes and its Complications. 31(7). 1145–1151. 23 indexed citations
5.
Pickwell, K., Volkert Siersma, Marleen Kars, et al.. (2015). Predictors of Lower-Extremity Amputation in Patients With an Infected Diabetic Foot Ulcer. Diabetes Care. 38(5). 852–857. 146 indexed citations
6.
Siersma, Volkert, Hanne Thorsen, P. Holstein, et al.. (2013). Health-Related Quality of Life Predicts Major Amputation and Death, but Not Healing, in People With Diabetes Presenting With Foot Ulcers: The Eurodiale Study. Diabetes Care. 37(3). 694–700. 66 indexed citations
7.
Bus, Sicco A., Roelof Waaijman, Mark P. Arts, et al.. (2013). Effect of Custom-Made Footwear on Foot Ulcer Recurrence in Diabetes. Diabetes Care. 36(12). 4109–4116. 214 indexed citations
8.
Prompers, L., M. Huijberts, Jan Apelqvist, et al.. (2007). Optimal Organization of Health Care in Diabetic Foot Disease: Introduction to the Eurodiale Study. The International Journal of Lower Extremity Wounds. 6(1). 11–17. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026